
Nitric Boost Ultra Issues 2025 Update on Nitric Oxide Support, Clean-Label Ingredient Trends, and Non-Synthetic Circulation Supplements for Men
Austin, June 28, 2025 (GLOBE NEWSWIRE) —
With a growing demand for nitric oxide–supportive supplements and clean-label performance products, Nitric Boost Ultra has released a 2025 formulation and ingredient transparency update. The brand's approach reflects the surge in consumer searches related to non-stimulant circulation support, amino acid-based energy formulas, and plant-aligned men's wellness tools. This release provides insight into how Nitric Boost Ultra's profile matches evolving expectations around ingredient sourcing, educational positioning, and lifestyle supplementation for vitality and endurance—without reliance on synthetic additives or prescription frameworks.
Introduction: Nitric Oxide Awareness and the Shift Toward Clean Supplementation
The concept of nitric oxide (NO) as a biological messenger has entered the mainstream health discussion in recent years, particularly among those interested in stamina, circulation, and performance. In 2025, a growing number of individuals are exploring natural, over-the-counter strategies that align with broader wellness values rather than clinical interventions. This shift is evidenced in rising keyword searches for terms like 'best nitric oxide booster for men,' 'natural ways to support blood flow,' and 'plant-based supplements for stamina.'
As a non-synthetic, soy-free, and stimulant-free formulation, Nitric Boost Ultra exists at the intersection of this modern movement. It offers a well-structured ingredient lineup with public-facing transparency, educational framing, and compatibility with plant-forward daily wellness goals. In an increasingly competitive market for male vitality products, this announcement reinforces the brand's commitment to clarity, not hype—providing the public with access to meaningful ingredient breakdowns and clear positioning within the non-clinical wellness sector.
Consumer Search Trends in 2025: A Spotlight on Nitric Oxide and Natural Circulation Support
Consumer behavior online continues to demonstrate heightened interest in nitric oxide-related supplements, especially those positioned as natural, stimulant-free, and part of a broader approach to energy and endurance. Google Trends and other search analytics tools show increased volume in queries such as: 'natural nitric oxide booster'
'non-stimulant pre-workout powder'
'amino acid powder for circulation'
'plant-based energy supplement for men'
'nitric oxide blood flow support stack'
This trend aligns with broader shifts in male consumer health preferences, where individuals seek to avoid synthetic stimulants or pharmaceuticals in favor of options rooted in clean nutrition and proactive self-care. Platforms like Reddit's r/Supplements, TikTok fitness commentary, and wellness-focused YouTube channels frequently feature discussions around nitric oxide–supportive ingredients, emphasizing circulation, performance, and confidence through natural strategies.
Nitric Boost Ultra was formulated to reflect—not lead—this shift. Rather than claim innovation, it offers clarity and transparency about ingredients already dominating the wellness conversation, such as L-Arginine, Beet Root, and L-Citrulline. As public search behavior continues to drive formulation decisions, brands that embrace user curiosity and platform feedback without promotional overreach are gaining increased traction.
2025 Formulation Overview: Nitric Boost Ultra's Plant-Aligned, Stimulant-Free Ingredient Structure
Nitric Boost Ultra's 2025 formulation profile includes a blend of amino acids, botanicals, and nutritional compounds selected for their roles in supporting nitric oxide production, energy metabolism, and circulatory health. The formula is stimulant-free, non-GMO, soy-free, and dairy-free—meeting consumer preferences for clean-label, transparent products.
Key Ingredients
Beet Root Powder: Known for its naturally occurring nitrates, beet root has gained popularity in endurance communities and among health-conscious consumers for its supportive role in vascular tone and oxygen efficiency. Its presence in NO-boosting formulations is both well-documented and increasingly requested in product reviews.
L-Arginine: As a direct precursor to nitric oxide in the body, L-Arginine is one of the most searched and studied amino acids in the performance support space. It plays a foundational role in the endothelial nitric oxide synthase (eNOS) pathway and is regularly featured in user-built supplement stacks.
L-Citrulline DL-Malate: This combination merges the NO-boosting potential of L-Citrulline (which converts into L-Arginine) with malate, which is associated with energy metabolism. The blend is known for supporting sustained performance, and its inclusion reflects search-driven preferences in both fitness and longevity supplements.
Horny Goat Weed (Icariin): Often mentioned in traditional wellness systems, Horny Goat Weed contains icariin, a bioactive compound that appears frequently in men's vitality formulations. Online interest in this botanical remains high, particularly in the context of circulation, confidence, and performance alignment.
Ginkgo Biloba: With a long-standing reputation for supporting blood flow and cognitive alertness, ginkgo continues to rank among the top-searched plant-based compounds in wellness communities. It is often noted for its antioxidant properties and synergy with other circulatory support ingredients.
The Nitric Boost Ultra formula is produced in a U.S.-based facility operating under Good Manufacturing Practices (GMP). The brand does not make medical claims or offer clinical guidance but emphasizes full ingredient transparency and responsible product labeling for lifestyle supplementation.
Aligning With the Clean Wellness Movement: Lifestyle Support Without Clinical Claims
2025 has seen a broad consumer push toward non-medical, non-stimulant solutions for endurance, energy, and confidence. As part of the broader clean-label movement, Nitric Boost Ultra was formulated to fit seamlessly into daily routines focused on long-term well-being, not instant transformation.
Unlike traditional performance supplements that lean heavily on caffeine or proprietary blends, Nitric Boost Ultra avoids masking its ingredient strategy. The formulation does not promise specific outcomes. Instead, it echoes the informational tone increasingly expected by supplement-savvy buyers: 'This is what's in it, here's how it aligns with your interests, and here's why it was chosen.'
By positioning itself as part of a transparent wellness toolkit—rather than as a shortcut to clinical results—Nitric Boost Ultra supports the evolving self-directed supplementation culture.
Ingredient Function Overview: How Each Component Supports Natural Nitric Oxide Pathways
Nitric oxide plays a vital role in vasodilation, or the widening of blood vessels, which in turn supports healthy blood flow, oxygen delivery, and muscular endurance. Ingredients in Nitric Boost Ultra were selected based on their relevance to the body's natural nitric oxide pathways and energy metabolism. L-Arginine supports the direct synthesis of nitric oxide through the eNOS pathway. This pathway is central to maintaining vascular tone and is commonly referenced in fitness literature for its endurance implications.
supports the direct synthesis of nitric oxide through the eNOS pathway. This pathway is central to maintaining vascular tone and is commonly referenced in fitness literature for its endurance implications. L-Citrulline is converted into L-Arginine in the kidneys, offering a secondary NO-boosting route that some experts consider more effective due to its slower, sustained release.
is converted into L-Arginine in the kidneys, offering a secondary NO-boosting route that some experts consider more effective due to its slower, sustained release. Beet Root Powder provides dietary nitrates that the body converts to nitric oxide via the nitrate-nitrite-NO pathway. This route bypasses enzymatic dependence and has gained favor in athletic supplementation circles.
provides dietary nitrates that the body converts to nitric oxide via the nitrate-nitrite-NO pathway. This route bypasses enzymatic dependence and has gained favor in athletic supplementation circles. Ginkgo Biloba and Horny Goat Weed contribute to circulatory and cognitive support. Though not direct NO precursors, these botanicals are frequently included in stacks aimed at comprehensive vascular health.
Together, these ingredients offer a multi-pathway approach to NO support without relying on synthetic enhancers or rapid-onset stimulants. The formulation offers an educational view of how common, well-researched compounds intersect with natural vitality.
Consumer Use Case Narratives: How Online Communities View Powder-Based Circulation Support
Discussions across Reddit, StackExchange, and social wellness groups increasingly show interest in powder-based supplements. Many users report supplement fatigue from daily capsules and prefer powders that dissolve into morning beverages or pre-workout routines. Nitric Boost Ultra, available in this format, reflects that preference without compromising on clean-label commitments.
Public forums show consistent curiosity in formulas that combine amino acids and botanicals for generalized energy support, especially when free from added sugars or chemical additives. While anecdotal experiences vary, recurring themes include: Appreciation for non-stimulant energy options
Interest in stacking beet root, citrulline, and ginkgo
Questions around daily use timing and synergy with exercise
Nitric Boost Ultra is not presented as a solution to any clinical need. Instead, it's discussed as a convenience-friendly powder that fits into user-built lifestyle strategies focused on clarity, self-regulation, and ingredient legitimacy.
Search-Informed Formulation: How Public Curiosity Shaped the 2025 Ingredient Update
Search data has shaped many aspects of the Nitric Boost Ultra development process. Rather than predicting what users want, the brand analyzed thousands of trending terms to identify existing interest clusters. Some of the fastest-growing queries include: 'best nitric oxide supplement 2025'
'beet root pre workout blood flow'
'natural energy powder for circulation'
'non-gmo nitric oxide stack for men'
Rather than attempting to define what works best, the brand reverse-engineered a formulation around these phrases—incorporating ingredients already researched, reviewed, and requested across forums. Nitric Boost Ultra is not a novelty; it is a response to real, repeated consumer behavior without positioning itself as an authority. This transparency-over-innovation approach appears to resonate in an increasingly educated supplement marketplace.
Access and Transparency: How the Brand Avoids Promotional Triggers While Educating the Market
Nitric Boost Ultra maintains an informational website where individuals can verify the full ingredient profile, sourcing philosophy, and manufacturing details. There are no endorsements, quotes, or incentivized sales tools present on the platform. Pricing is not used as a conversion tactic, and there are no limited-time offers or urgency-based promotions.
Transparency efforts include: Full ingredient list with sourcing background
Clear dietary disclosures (non-GMO, soy-free, dairy-free)
No clinical claims or disease treatment language
GMP certification details for manufacturing
This content-forward, compliance-focused strategy prioritizes long-term brand trust over short-term conversions—positioning Nitric Boost Ultra as a reliable reference in the nitric oxide category.
Industry Context: Responsible Formulation in a Crowded Nitric Oxide Market
As regulation increases in the health supplement space, companies are under pressure to separate educational content from promotional messaging. Nitric Boost Ultra embraces this boundary by structuring its product as an option—not a solution.
Its existence within the nitric oxide sector supports a responsible model for supplement disclosure: ingredient-based, user-informed, and publication-safe. Rather than adopting exaggerated claims, Nitric Boost Ultra fosters a climate of inquiry—where users explore, compare, and contextualize ingredients within their own routines.
Public Commentary Summary: Search Sentiment Themes From Wellness Conversations
Emerging positives: Appreciation for clean-label powder format
Recognition of popular, stackable ingredients
Favorable discussion of beet root and ginkgo synergy
Cautionary trends: Desire for third-party user studies
Emphasis on realistic expectations around lifestyle support
Ongoing comparisons to conventional nitric oxide pills or pre-workout blends
These themes are not endorsements but reflect the general sentiment from independent wellness audiences and communities seeking clarity in a complex supplement marketplace.
About Nitric Boost Ultra
Nitric Boost Ultra is a wellness formulation created by a U.S.-based team focused on plant-aligned innovation, transparency, and lifestyle-based performance support. The formula is designed for adults seeking stimulant-free circulation and energy alignment without medicalization or prescription dependency.
The brand does not diagnose or treat health conditions. Instead, it supports informational empowerment through ingredient transparency and clean manufacturing standards.
Contact
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Buzz Feed
29 minutes ago
- Buzz Feed
Genius Life Hacks That Actually Work
Sometimes the littlest things can make your daily routine *so* much easier. Reddit user ActuallyInFamous recently asked, "What is a life hack that actually has worked for you?" Here are the most helpful responses everyone should try at least once: "Not looking at my clock, watch, phone, or anything when I'm going to bed. Even as much as I want to, when I can't fall asleep, I resist. Seeing what time it is and panicking about it helps no one. Works like a charm for my sleep." "Be nice first — until they give you a reason not to be nice." "If it's on your mind, handle it right away. Don't lie in bed thinking, 'Aw man, I should have done so and so or this and that.' This goes for the dishes, eating cake, and taking your dream vacation. If at all possible, try to have fewer 'what-ifs' in life." "Having a place for the important things and putting them there when I am through with them." "No more than two lights on per person. No lights on as long as the sun is up and out." "Folding matching sheets, duvet cover, and pillow cases inside a pillow case, after washing them. Then I don't have to hunt for all the bits of the matching sets when I change the bedding." "I keep a running Microsoft Word document for all work notes. Today's are on top. Super easy to refer back to. I start a new file about once a year." "If you can do it in two minutes, do it now." "The sugar craving is the same craving for water, somewhat. If you're having a sweet tooth, try a glass of water; odds are you are dehydrated." "Before leaving a table at a restaurant, a hotel room, your plane seat, the backseat of an Uber, etc., take an extra moment to turn around and look at where you were. You'd be surprised at what you forgot to take with you." "Clean the kitchen and wash dishes while I'm cooking. It is frustrating trying to clean a dirty kitchen after you've eaten. You're full, tired, and don't want to do anything. It's better to clean as you cook." "Wearing a goofy grin on my face whenever I can. It turns out to be a great mood brightener. That being said, 'don't put it down, put it away' is absolutely brilliant." "I fold the laundry as I take it out of the dryer. I'm more likely to put it away right away as opposed to living out of the basket of unfolded laundry." "No eating in my room. The dishes end up staying there until they're well past disgusting." "I used to snooze a lot, and then I decided I would start getting up immediately after the clock goes off, not read my phone or anything, just get up. I get more sleep and I have more energy throughout the day." "Putting the sun visors down and against the windshield will actually help defog/defrost it faster." "Getting the breakfast table ready the night before so I have a little more time in the morning, and just have to add the things that could spoil. I would do this right after dinner, and it always made me happy in the morning when I had to take my daughter to school and had a lot to do. I even had a tray with all the items that didn't need to be kept in the fridge, so I'd just have to take it out of the kitchen closet, plus the items from the fridge. The breakfast table was complete in 30 seconds every morning, which is a very relaxing way to start the day." "Quitting alcohol." "Learn to sew by hand. You don't need to be that skilled. Sew on the loose button, mend the torn seam, and patch it up generally. A younger friend of mine took her coat to a dry cleaners and they said, 'Do you want us to tighten the buttons for you?' She said yes. I think she thought it was a courtesy thing, and it was £3 per button. There were eight buttons, six on the coat and two on the cuffs. I told her next time I would do the buttons for her." "If you have to do something unpleasant, do it properly so that you only have to do it once." "Make your bed in the morning. That way, even if you do nothing all day, you will have accomplished something." What's your best life hack? Share yours in the comments! Note: Some responses have been edited for length and/or clarity.


Business Upturn
4 hours ago
- Business Upturn
Cardiovascular Information System Market to Reach USD 2.8 Billion by 2032, Driven by Digital Health Advancements and Growing Cardiac Care Needs
Austin, June 29, 2025 (GLOBE NEWSWIRE) — Cardiovascular Information System Market Size & Growth Analysis: According to SNS Insider, the Cardiovascular Information System Market was valued at USD 1.24 billion in 2023 and is projected to reach USD 2.8 billion by 2032, growing at a CAGR of 9.4% over the forecast period of 2024–2032. The increasing prevalence of cardiovascular diseases and the need for extensive data management in cardiac care are driving the growth of the global cardiovascular information system market. Emerging technologies including cloud-based solutions, artificial intelligence, and EHR interoperability, are filling clinical workflows. Furthermore, increasing digitization of healthcare, in addition to an improved patient outcomes plan, is anticipated to propel widespread adoption of CVIS across hospitals & specialty care centers. Get a Sample Report of Cardiovascular Information System Market@ The U.S. cardiovascular information system market was estimated at USD 0.33 billion in 2023 and is expected to reach USD 0.73 billion by 2032, at a CAGR of 8.64% during the forecast period of 2024-2032 The North American cardiovascular information system market is dominated by the U.S., attributable to high-end healthcare infrastructure combined with high acceptance of electronic health records and huge investments in digital health technologies. The major CVIS vendors based in this country, coupled with the large number of cardiovascular procedures performed, are continuing to drive the U.S. to a commanding lead in the region. Major Players Analysis Listed in this Report are: Philips Healthcare (IntelliSpace Cardiovascular, Xcelera) Siemens Healthineers (syngo Dynamics, GE Healthcare (Centricity Cardio Enterprise, MUSE Cardiology Information System) McKesson Corporation (McKesson Cardiology, Horizon Cardiology) Agfa Healthcare (IMPAX CV, Enterprise Imaging for Cardiology) Fujifilm Medical Systems (Synapse Cardiovascular, Synapse VNA) LUMEDX Corporation (CardioStar, HealthView CVIS) Cerner Corporation (PowerChart Cardiovascular, CVNet) Merge Healthcare (an IBM Company) (Merge Cardio, Merge Hemo) Digisonics Inc. (DigiView, DigiNet Pro) Cardiovascular Information System Market Report Scope Report Attributes Details Market Size in 2023 US$ 1.24 Billion Market Size by 2032 US$ 2.8 Billion CAGR CAGR of 9.4% From 2024 to 2032 Base Year 2023 Forecast Period 2024-2032 Historical Data 2020-2022 Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis: Based on the System, the CVIS Segment Leads the Market In 2023, the cardiovascular information system (CVIS) segment held the highest market share due to the fact that it supports the management, storage, and analysis of cardiovascular data from multiple modalities. By enabling image archiving, real-time access, and clinical EHR integration, CVIS boosts workflow efficiency in cardiac care. Use has also grown, due to the growing need for centralized data management and interoperability within healthcare settings. Web-Based Segment Dominates the Market by Mode of Operation The web-based segment accounted for the largest share in 2023 with a 73% market share, owing to the ease with which this type of system can be deployed, its scalability, and cost-effectiveness. These are essential systems for timely decision-making in cardiovascular care, and their connectivity helps provide real-time access to patient data from various locations. Because they demand little to no infrastructure and integrate easily with existing hospital networks, healthcare providers are increasingly opting for a web-based system. By End User, the Hospitals Segment dominated the Cardiovascular Information System Market The hospital segment accounted for the highest share of the CVIS market in 2023. Due to the high number of cardiovascular procedures carried out in a hospital setting, as well as the healthcare organizations' demand for integrated data management systems. SCV and other partners' healthcare professionals, complex imaging workflows, imaging data, and patient records that hospitals manage require comprehensive solutions such as CVIS. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Cardiovascular Information System Market Segmentation By Mode Of Operation Web-based Cloud-based On-site By System By End User Hospitals Large Hospitals Medium-sized Hospitals Small Hospitals Diagnostic Centers Regional Trends: North America to Dominate Cardiovascular Information System Market; Asia-Pacific to Witness Fastest Growth The cardiovascular information system (CVIS) market was dominated by North America in 2023, with 37% market share, owing to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and early adoption of health IT systems in this region. From the perspective of the growth factors, major industry presence, solid government support & initiatives for EHR, and large investment in hospitals' digitization were a few that complemented the market growth. The Asia-Pacific region is anticipated to exhibit the fastest growth over the forecast period in the cardiovascular information system market. Some of the major factors driving the growth of the cardiovascular diagnostics market are rapid urbanization, increasing healthcare spending, and increasing awareness of the importance of good cardiovascular health. Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 5.1 Adoption Rates of CVIS, 2023 5.2 Device Integration Trends, 2023 5.3 Healthcare Spending on CVIS, by Region, 2023 5.4 Regulatory Compliance and Standardization Trends 5.5 Feature Adoption Trends, 2023 6. Competitive Landscape 7. Cardiovascular Information System Market by Mode Of Operation 8. Cardiovascular Information System Market by System 9. Cardiovascular Information System Market by End User 10. Regional Analysis 11. Company Profiles 12. Use Cases and Best Practices 13. Conclusion Buy a Single-User PDF of Cardiovascular Information System Market Analysis & Outlook Report 2024-2032@ About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash


Business Upturn
9 hours ago
- Business Upturn
Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair
By GlobeNewswire Published on June 29, 2025, 16:00 IST Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches at The Championships, Wimbledon in 2025. The world's oldest and most prestigious tennis tournament serves as a perfect backdrop to showcase Smith+Nephew's purpose of 'Life Unlimited' – making a difference in patients' lives through the excellence of a diverse Sports Medicine product portfolio and the application of new technologies. Tennis is a high-impact sport that places great stress on various areas of the body – especially joints – often resulting in injury. Some of the latest technologies and solutions from Smith+Nephew for joint repair include: REGENETEN◊ Bioinductive Implant: With more than 150,000 procedures1 completed globally since its introduction in 2014, the REGENETEN Bioinductive Implant has had a transformative impact amongst those having surgery for rotator cuff tears; demonstrating lower re-tear rates than reported compared to conventional techniques.2-6 Backed by level one clinical evidence,2 the collagen-based implant supports the body's natural healing response to facilitate the formation of new tendon-like tissue to biologically augment the existing tendon and change the course of rotator cuff tear progression.7-12 CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant: Derived from a naturally occurring calcium carbonate known as aragonite, the CARTIHEAL Implant is a biphasic scaffold for cartilage repair and subchondral bone restoration.13-15 Shown to deliver clinically meaningful post-operative improvements in pain, function and quality of life,* the CARTIHEAL Implant is the only device approved for the treatment of knee cartilage and osteochondral defects in patients with or without mild to moderate osteoarthritis (KL 0-3).13,16 Q-FIX◊ KNOTLESS All-Suture Anchor: Building on the long-standing success and performance of the Q-FIX Family for best-in-class anchor fixation strength,**,17-21 the new Q-FIX KNOTLESS All-Suture Anchor raises the bar for all-suture anchor technology. With proprietary features and capabilities, the Q-FIX KNOTLESS All-Suture Anchor aims to set a new benchmark for soft tissue security†,22 and offer surgeons a new option for soft tissue-to-bone fixation indications across multiple joint spaces. 'Our inaugural turn sponsoring select players during The Championships, Wimbledon in 2024 was a tremendous success supporting athletes from across the globe – including Jasmine Paolini all the way to the Ladies Final,' said Christie van Geffen, SVP Global Sports Medicine Marketing for Smith+Nephew. 'We were able to uniquely feature the Smith+Nephew brand along with our leading Sports Medicine technology portfolio – designed to help weekend warriors and world-class athletes get back to competing and doing what they love.' If you would like to learn more about Smith+Nephew's leading Sports Medicine technology portfolio – including the CARTIHEAL AGILI-C Cartilage Repair Implant, the REGENETEN Bioinductive Implant and the Q-FIX KNOTLESS All-Suture Anchor – please visit here. – ends – Media Enquiries Dave Snyder +1 (978) 749-1440 Smith+Nephew [email protected] *Over a 2 and 4 year follow up **As compared to competitive devices in fixation/pull-out benchtop testing †As compared to the competitive device in cyclic benchtop testing References Smith+Nephew. Internal Data. Ruiz Ibán MÁ, García Navlet M, Moros Marco S, et al. Augmentation of a Transosseous-Equivalent Repair in Posterosuperior Nonacute Rotator Cuff Tears With a Bioinductive Collagen Implant Decreases the Retear Rate at One Year: A Randomized Controlled Trial. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2023:1-14. Bushnell BD, Connor PM, Harris HW, et al. Retear rates and clinical outcomes at 1 year after repair of full-thickness rotator cuff tears augmented with a bioinductive collagen implant: a prospective multicenter study. JSES international. 2021;5(2):228. Hein J, Reilly JM, Chae J, Maerz T, Anderson K. Retear Rates After Arthroscopic Single-Row, Double Row, and Suture Bridge Rotator Cuff Repair at a Minimum of 1 Year of Imaging Follow-up: A Systematic Review. Arthroscopy. 2015;31(11):2274-2281. Camacho-Chacon JA, Cuenca-Espierrez J, Roda-Rojo V, et al. Bioinductive collagen implants facilitate tendon regeneration in rotator cuff tears. J Exp Orthop. 2022;9(1):53. Smith + Nephew overview of the outcomes associated with the standard of care for the surgical treatment of rotator cuff tears. Internal Report EO/SPM/REGENETEN/005/v1. Bokor DJ, Sonnabend D, Deady L, et al. Evidence of healing of partial-thickness rotator cuff tears following arthroscopic augmentation with a collagen implant: a 2-year MRI follow-up. Muscles, Ligaments Tendons J. 2016;6(1):16-25. Schlegel TF, Abrams JS, Bushnell BD, Brock JL, Ho CP. Radiologic and clinical evaluation of a bioabsorbable collagen implant to treat partial-thickness tears: a prospective multicenter study. J Shoulder Elbow Surg. 2018 27(2):242-251. Van Kampen C, Arnoczky S, Parks P, et al. Tissue-engineered augmentation of a rotator cuff tendon using a reconstituted collagen scaffold: a histological evaluation in sheep. Muscles Ligaments Tendons J. 2013;3(3):229-235. Arnoczky SP, Bishai SK, Schofield B, et al. Histologic Evaluation of Biopsy Specimens Obtained After Rotator Cuff Repair Augmented With a Highly Porous Collagen Implant. Arthroscopy. 2017;33(2):278-283 Bokor DJ, Sonnabend DH, Deady L, et al. Healing of partial-thickness rotator cuff tears following arthroscopic augmentation with a highly porous collagen implant: a 5-year clinical and MRI follow-up. Muscles, Ligaments Tendons J. 2019;9(3):338-347. McElvany MD, McGoldrick E, Gee AO, Neradilek MB, Matsen FA, 3rd. Rotator cuff repair: published evidence on factors associated with repair integrity and clinical outcome. Am J Sports Med. 2015;43(2):491-500. Altschuler N, Zaslav KR, Di Matteo B, et al. Aragonite-Based Scaffold Versus Microfracture and Debridement for the Treatment of Knee Chondral and Osteochondral Lesions: Results of a Multicenter Randomized Controlled Trial. Am J Sports Med. 2023;51(4):957-967. doi:10.1177/03635465231151252 Kon E, Di Matteo B, Verdonk P, et al. Aragonite-Based Scaffold for the Treatment of Joint Surface Lesions in Mild to Moderate Osteoarthritic Knees: Results of a 2-Year Multicenter Prospective Study. Am J Sports Med. 2021;49(3):588-598. Kon E, Filardo G, Shani J, et al. Osteochondral regeneration with a novel aragonite-hyaluronate biphasic scaffold: up to 12-month follow-up study in a goat model. J Orthop Surg Res. 2015;10:81. Conte P, Anzillotti G, Crawford DC, et al. Differential analysis of the impact of lesions' location on clinical and radiological outcomes after the implantation of a novel aragonite-based scaffold to treat knee cartilage defects. Int Orthop. 2024;48(12):3117-3126 Douglass NP, et al. Arthroscopy. 2017;33(5):977-985 e975. Ergun S, et al. Arthroscopy. 2020; 2(3):e263-e275. Smith+Nephew 2023. Internal Report. 10090792- Revision B. ArthroCare Corporation 2017. Internal Report. P/N 49190-03 Rev. B. Smith+Nephew 2024. Internal Report. 10144423 Rev B. Smith and Nephew 10144423 Rev B About Smith+Nephew Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 17,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, we now operate in around 100 countries, and generated annual sales of $5.8 billion in 2024. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise. For more information about Smith+Nephew, please visit and follow us on X, LinkedIn, Instagram or Facebook. Forward-looking Statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as 'aim', 'plan', 'intend', 'anticipate', 'well-placed', 'believe', 'estimate', 'expect', 'target', 'consider' and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC's website at www. for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations. ◊ Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.